Basics Monte Rosa Therapeutics, Inc. IPO Date: June 24, 2021 Sector: Healthcare Industry: Biotech Market Cap: $1.13B Activated in VL: True Average Daily Range Avg Daily Range: $0.40 | 4.18% Avg Daily Range (30 D): $0.57 | 4.39% Avg Daily Range (90 D): $0.35 | 3.84% Institutional Daily Volume Avg Daily Volume: .39M Avg Daily Volume (30 D): .89M Avg Daily Volume (90 D): 1.03M Trade Size Avg Trade Size (Sh.): 88 Avg Trade Size (Sh.) (30 D): 69 Avg Trade Size (Sh.) (90 D): 83 Institutional Trades Total Inst.Trades: 292 Avg Inst. Trade: $2.47M Avg Inst. Trade (30 D): $1.37M Avg Inst. Trade (90 D): $1.55M Avg Inst. Trade Volume: .26M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.17M Avg Closing Trade (30 D): $1.28M Avg Closing Trade (90 D): $1.12M Avg Closing Volume: 190.2K     News Nov 8, 2025 @ 4:30 PM Monte Rosa Therapeutics Presents Preclinical Data ... Source: Monte Rosa Therapeutics Nov 3, 2025 @ 12:00 PM Monte Rosa Therapeutics to Participate in Upcoming... Source: Monte Rosa Therapeutics Oct 24, 2025 @ 11:00 AM Monte Rosa Therapeutics Presents Preclinical Data ... Source: Monte Rosa Therapeutics Sep 15, 2025 @ 3:29 PM Monte Rosa, Novartis Use AI-Powered Engine To Adva... Source: Vandana Singh Sep 15, 2025 @ 11:00 AM Monte Rosa Therapeutics Announces Collaboration wi... Source: Monte Rosa Therapeutics Financials   TTM Q3 2025 Q2 2025 Basic EPS Diluted EPS Revenue $ 181.54M $ 12.77M $ 23.19M Gross Profit $ $ $ Net Income / Loss $ 20.95M $ -27.08M $ -12.3M Operating Income / Loss $ 8.51M $ -32.98M $ -15.55M Cost of Revenue $ $ $ Net Cash Flow $ 82.81M $ 138.91M $ -9.03M PE Ratio